Here are four quick facts:
1. Eleven analysts agree with this consensus.
2. The higher estimate for the short term price target is $74 while the lower estimate is $64.
3. The 52-week high of the share price is $63.89 and the 52-week low is $48.73.
4. The company has a market cap of $4.3 billion.
More articles on anesthesia:
Dr. Brooke Vanderby joins Illinois Bone & Joint Institute: 4 quick facts
Somnia Anesthesia names Diana Allen VP of patient revenue — 5 quick facts
U.S. Anesthesia Partners, Medical Anesthesia and Pain Management Consultants merge: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.